Philip Hieter is a Professor in the Michael Smith Laboratories and the Department of Medical Genetics, and an Associate Member of the Department of Biochemistry and Molecular Biology at the University of British Columbia.
Dr. Hieter received his Ph.D. in Biochemistry from Johns Hopkins University in 1981 (with Phil Leder, human antibody genes). He trained as a postdoctoral fellow at Stanford University (with Ron Davis, yeast centromeres) and then returned to Johns Hopkins University School of Medicine, Department of Molecular Biology and Genetics, as a faculty member in 1985, where he was promoted to Full Professor in 1994. In 1997, he joined the University of British Columbia as a Professor in the Department of Medical Genetics and served as Director of the Michael Smith Laboratories until July 2008.
Dr. Hieter was elected to the Royal Society of Canada in 2005, and to the Canadian Academy of Health Sciences in 2011. He was elected Fellow of the American Academy of Microbiology (1998), and of the American Association for the Advancement of Science (2005). He is currently a Fellow of the Canadian Institute for Advanced Research. In 2012, Dr. Hieter was elected to the American Academy of Arts and Sciences.
Dr. Hieter served on the founding Institute Advisory Board of the Institute of Genetics (CIHR) from 2001 to 2005. He served on the Board of Scientific Counselors for the National Human Genome Research Institute (NIH) from 2001 to 2006, serving as Chair from 2004 to 2006. Dr. Hieter served as Chair of the CIHR Planning and Priorities Committee “Integrating the Physical and Applied Sciences into Biomedical Research” from 2001 to 2011, and is currently Chair of the CIHR Planning and Priorities Committee “Models and Mechanisms to Therapies”. He serves on the advisory boards of Saccharomyces Genome Database (SGD) and several other research organizations in Canada and the United States. Dr. Hieter served as President of the Genetics Society of America in 2012.
Dr Hieter is recognized for his work on structural and regulatory proteins that ensure faithful segregation of chromosomes during cell division, including seminal studies on yeast centromeres, sister chromatid cohesion, and regulation of cell cycle progression during mitosis. Throughout his career, his work has demonstrated and advocated the value of yeast and other model experimental organisms for understanding mechanisms of human disease. Since the early 90’s, he has been a major spokesperson in arguing the need for increased support of basic research and has actively promoted collaboration between medical and basic scientists.